July 9, 2019
CAR-T Cell Therapy for Pancreatic Cancer
Explore how CAR-T cell therapy is showing promise as a novel treatment strategy for pancreatic cancer.
LEARN MORE
June 11, 2019
Orthotopic or Subcutaneous Tumor Homograft Models?
When should you use either subcutaneous or orthotopic pancreatic cancer tumor homografts, and where do they best ...
LEARN MORE
April 3, 2019
New Analysis, Model ID, and Modeling Technologies at AACR 2019
In Atlanta this week we’re presenting data on our new analysis platforms and preclinical technologies. This post recaps ...
LEARN MORE
April 2, 2019
Syngeneic and Tumor Homograft Immuno-Oncology Models at AACR 2019
Recap all our AACR presentations on murine models including bioluminescent orthotopic syngeneic models, syngeneic model ...
LEARN MORE
April 1, 2019
Humanized Model Update at AACR 2019
Review all the new data on our humanized target models for human-specific CD40 and combination regimen assessment, and ...
LEARN MORE
April 1, 2019
AACR19 Analysis: PDX and PDX-Derived Organoid Models
Review all the new data on patient-derived xenograft (PDX) models we’re presenting at AACR 2019 this week, including ...
LEARN MORE
March 6, 2019
Using Genetic Features to ID and QC Murine Tumor Models
Learn how unique genetic events can be used to generate a “genetic fingerprint” to ID and QC murine tumor models.
LEARN MORE
March 1, 2019
Novel Uses for PDX Models in Preclinical Drug Development
Learn how unique PDX models are used to support clinical drug development, discover predictive gene signatures, and for ...
LEARN MORE
February 5, 2019
Beginners Guide to PBMC Humanized Tumor Models
Discover PBMC-humanized tumor models for short-term immunotherapy assessment studies.
LEARN MORE
January 31, 2019
How to Test Human-Specific Combination Immunotherapies In Vivo
Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug ...
LEARN MORE
December 24, 2018
NASH 2018 Review: Improving Awareness and Potential New Therapies
A look back at NASH over the course of 2018, with a focus on raising disease awareness and an update on clinical trial results.
LEARN MORE
November 15, 2018
Prostate Cancer PDX Models and Oncology Analysis Studies: ENA 2018
This week at ENA 2018, we’re presenting up to date research on our PDX models, including our newly developed prostate ...
LEARN MORE
November 15, 2018
Murine Immuno-Oncology Models: ENA 2018
At ENA 2018 we’re presenting new data on our wide range of immuno-oncology (I/O) platforms, with four posters covering ...
LEARN MORE
November 14, 2018
Humanized Immuno-Oncology Model Update: ENA 2018
This week, at ENA Dublin 2018, we’re presenting new data from our novel humanized in vivo preclinical platforms. This ...
LEARN MORE
October 24, 2018
PDX Study Investigates Cetuximab for Esophageal Cancer
Esophageal cancer patients lack targeted agent treatment options, leaving them with a poor prognosis ...
LEARN MORE
